Literature DB >> 2394690

Accumulation of human apolipoprotein E in the plasma of transgenic mice.

J D Smith1, A S Plump, T Hayek, A Walsh, J L Breslow.   

Abstract

Three separate lines of transgenic mice were created with integrated copies of an 11.1-kilobase pair human DNA fragment containing the apolipoprotein (apo) E gene. The endogenous mouse apoE gene is primarily expressed in the liver with varying levels of expression in other tissues. However, in all three transgenic lines high levels of human apoE mRNA were detected only in the kidney, with lower levels found in the liver and other tissues; despite this profile of human apoE mRNA, human apoE was found in the plasma of the transgenic mice at levels comparable to those found in human plasma. All of the human apoE in the plasma of the transgenic mice was associated with lipoproteins. These results suggest that the domain responsible for the high level of apoE expression in liver lies outside of the microinjected DNA fragment and that an ectopic site of expression of an introduced gene may be permissive for the accumulation of its protein in plasma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2394690

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein Cl.

Authors:  N S Shachter; T Ebara; R Ramakrishnan; G Steiner; J L Breslow; H N Ginsberg; J D Smith
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

2.  Apolipoprotein E gene expression is reduced in apolipoprotein A-I transgenic mice.

Authors:  R A Srivastava
Journal:  Mol Cell Biochem       Date:  2000-06       Impact factor: 3.396

3.  Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice.

Authors:  T Ebara; K Conde; Y Kako; Y Liu; Y Xu; R Ramakrishnan; I J Goldberg; N S Shachter
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

4.  Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia.

Authors:  H Shimano; N Yamada; M Katsuki; M Shimada; T Gotoda; K Harada; T Murase; C Fukazawa; F Takaku; Y Yazaki
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

5.  Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice.

Authors:  N S Shachter; T Hayek; T Leff; J D Smith; D W Rosenberg; A Walsh; R Ramakrishnan; I J Goldberg; H N Ginsberg; J L Breslow
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

6.  Cytochrome P450 1A1 promoter as a genetic switch for the regulatable and physiological expression of a plasma protein in transgenic mice.

Authors:  J D Smith; E Wong; M Ginsberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

Review 7.  Transgenic mouse models of lipoprotein metabolism and atherosclerosis.

Authors:  J L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

Review 8.  Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.

Authors:  Katie L Pennington; Margaret M DeAngelis
Journal:  Eye Vis (Lond)       Date:  2016-12-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.